Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration of up to $200 million in cash.
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
Shares of AMC Entertainment Holdings Inc (NYSE:AMC) nearly doubled during Friday's after-market session to trade above $8 on news that sent shares of its counterpart, AMC Entertainment Hldg Pref Equity Units (NYSE:APE)&nb